Fresenius Medical Care AG - ADR
NYSE:FMS
Market Cap (Intraday) | 11.34B |
Current PE | 14.89 |
Forward PE | 13.33 |
2yr Forward PE | 10.37 |
10-Day MA | $20.30 |
50-Day MA | $19.83 |
200-Day MA | $19.81 |
Fresenius Medical Care AG - ADR Stock, NYSE:FMS
Else-Kr�¶ner-Strasse 1, Bad Homburg, Hessen 61352
Germany
Phone: +49.6172.609.0
Number of Employees: 119845
Description
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.